Next Round For Commissioner Nominee: Crawford Placed On Hold After Clearing Senate Health Committee
This article was originally published in The Pink Sheet Daily
Executive Summary
The nomination of Acting Commissioner Crawford to the permanent FDA post passed the committee. A full Senate vote will be delayed by a long-anticipated hold placed by Sens. Murray and Clinton, who demand the agency first make a decision on the OTC switch of Barr's Plan B emergency contraceptive.
You may also be interested in...
Von Eschenbach Nominated For FDA Commissioner Under Threat Of Hold
Sens. Clinton (D-N.Y.) and Murray (D-Wash.) demand a decision on Plan B to avoid a hold, employing the same tactic they used during the confirmation of former Commissioner Lester Crawford.
Von Eschenbach Nominated For FDA Commissioner Under Threat Of Hold
Sens. Clinton (D-N.Y.) and Murray (D-Wash.) demand a decision on Plan B to avoid a hold, employing the same tactic they used during the confirmation of former Commissioner Lester Crawford.
FDA's Plan B OTC Switch Decision Deadline Is Sept. 1, HHS' Leavitt Says
Sens. Clinton and Murray lift their hold on FDA Acting Commissioner Crawford's nomination after a letter from HHS secretary says FDA action on Barr's Rx-to-OTC switch application is imminent.